Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,849.24
+9.730.53%
Number of Gainers:10
Number of Losers:9
Number of Flat:- -
PE:- -
High:1,855.16
Open:1,840.14
Low:1,840.14
Close:1,839.40
Volume:18.50M
Turnover:1.27B
Market Cap:1.50T
Float Cap:1.47T

Loading ...

Pharma Sector Doubles Down on AI to Slash Costs, Timelines

Reuters
·
1 hour ago

Co-Diagnostics Teams with ReadyGo to Evaluate Blood-Based PCR Testing for Decentralized Ebola Detection

Reuters
·
2 hours ago

Co-Diagnostics and Readygo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

THOMSON REUTERS
·
2 hours ago

Lakeland Unit California PPE Launches CO₂ Turnout-Gear Cleaning System at Riverside Facility

Reuters
·
2 hours ago

Gilead - Expands Six Royalty-Free Voluntary Licensing Agreements for Once-Yearly Lenacapavir for Hiv Prevention

THOMSON REUTERS
·
2 hours ago

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Dow Jones
·
3 hours ago

AstraZeneca's Long-Term Outlook Could Look Safer After Next Year

Dow Jones
·
5 hours ago

AstraZeneca Can Meet 2030 Target Even if Lung-Cancer Trial Fails

Dow Jones
·
6 hours ago

BioNTech price target raised to $140 from $132 at Berenberg

TIPRANKS
·
6 hours ago

Rohto Starts Phase II Trial of RE-01 Cell Therapy for Refractory Ischemic Leg Ulcers

Reuters
·
11 hours ago

Co-Diagnostics - Enters Material Transfer Agreement with Readygo Diagnostics in August 2026 - SEC Filing

THOMSON REUTERS
·
19 hours ago

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live
·
20 hours ago

Cboe data shows mixed options sentiment in Moderna with shares down 2.14%

TIPRANKS
·
20 hours ago

AstraZeneca price target lowered to 150 GBp from 160 GBp at Berenberg

TIPRANKS
·
22 hours ago

Gilead Sciences Expands Lenacapavir Access to 14 Countries

MT Newswires Live
·
Yesterday

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
Yesterday

As Trump Backs Psychedelics Research, FDA Weighs Safety and Access Standards

Reuters
·
Yesterday

Gilead announces agreement with PAHO for lenacapavir access

TIPRANKS
·
Yesterday

Gilead: Agreement Establishes Regional Pathway Through Pan American Health Organization's Regional Revolving Funds

THOMSON REUTERS
·
Yesterday

Gilead: Co & Paho Announce Partnership to Accelerate Access to Twice-Yearly Lenacapavir for Hiv Prevention Across Latin America & Caribbean

THOMSON REUTERS
·
Yesterday